深度学习在乳腺X线摄影中的应用:多用途图像分析软件检测乳腺癌的诊断准确性
这项回顾性、双中心研究评估了基于深度学习和人工神经网络的多用途图像分析软件在乳腺X线摄影中检测乳腺癌的诊断准确性。该软件在内部数据集上的AUC为0.79(训练集为0.81),与一名放射科医师表现接近(AUC 0.83),但另两名放射科医师显著更优(AUC 0.91和0.94)。在类筛查队列中,神经网络AUC为0.82,与放射科医师(AUC 0.77-0.87)无显著差异,但放射科医师敏感性较低、特异性较高。
要点
- 在类筛查低患病率队列中,神经网络AUC为0.82,与放射科医师(0.77-0.87)无显著差异。
- 在内部测试集上,神经网络AUC为0.79,与训练集0.81相当(P=0.63)。
- 放射科医师敏感性低于神经网络,但特异性高于神经网络。
核心结论
- 当前最先进的通用图像分析人工神经网络在乳腺X线摄影中检测癌症的准确性与放射科医师相似,即使在低乳腺癌患病率的类筛查队列中也是如此。
研究设计与样本
- 回顾性、双中心研究,符合《健康保险流通与责任法案》;2012年在本机构接受乳腺X线摄影的患者共3228例,参考标准为组织学或临床长期随访;从公开的乳腺癌数字存储库数据集中选取35例癌症患者及35例匹配对照作为外部测试集;三名放射科医师(经验分别为3年、5年和10年)评估测试数据集;采用Bonferroni校正,P值小于0.016认为有统计学意义。
诊断标准与关键数值
- 在第一步中,训练后神经网络的受试者工作特征曲线下面积为0.81,在测试病例上为0.79(P=0.63);一名放射科医师表现几乎相同(AUC 0.83,P=0.17),另两名放射科医师显著更优(AUC分别为0.91和0.94,P<0.016)。在第二步中,神经网络AUC为0.82,与人类表现(AUC 0.77-0.87,P>0.016)无显著差异,但放射科医师的敏感性 consistently 较低、特异性较高。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to evaluate the diagnostic accuracy of a multipurpose image analysis software based on deep learning with artificial neural networks for the detection of breast cancer in an independent, dual-center mammography data set.
MATERIALS AND METHODS: In this retrospective, Health Insurance Portability and Accountability Act-compliant study, all patients undergoing mammography in 2012 at our institution were reviewed (n = 3228). All of their prior and follow-up mammographies from a time span of 7 years (2008-2015) were considered as a reference for clinical diagnosis. After applying exclusion criteria (missing reference standard, prior procedures or therapies), patients with the first diagnosis of a malignoma or borderline lesion were selected (n = 143). Histology or clinical long-term follow-up served as reference standard. In a first step, a breast density-and age-matched control cohort was selected (n = 143) from the remaining patients with more than 2 years follow-up (n = 1003). The neural network was trained with this data set. From the publicly available Breast Cancer Digital Repository data set, patients with cancer and a matched control cohort were selected (n = 35 × 2). The performance of the trained neural network was also tested with this external data set. Three radiologists (3, 5, and 10 years of experience) evaluated the test data set. In a second step, the neural network was trained with all cases from January to September and tested with cases from October to December 2012 (screening-like cohort). The radiologists also evaluated this second test data set. The areas under the receiver operating characteristic curve between readers and the neural network were compared. A Bonferroni-corrected P value of less than 0.016 was considered statistically significant.
RESULTS: Mean age of patients with lesion was 59.6 years (range, 35-88 years) and in controls, 59.1 years (35-83 years). Breast density distribution (A/B/C/D) was 21/59/42/21 and 22/60/41/20, respectively. Histologic diagnoses were invasive ductal carcinoma in 90, ductal in situ carcinoma in 13, invasive lobular carcinoma in 13, mucinous carcinoma in 3, and borderline lesion in 12 patients. In the first step, the area under the receiver operating characteristic curve of the trained neural network was 0.81 and comparable on the test cases 0.79 (P = 0.63). One of the radiologists showed almost equal performance (0.83, P = 0.17), whereas 2 were significantly better (0.91 and 0.94, P < 0.016). In the second step, performance of the neural network (0.82) was not significantly different from the human performance (0.77-0.87, P > 0.016); however, radiologists were consistently less sensitive and more specific than the neural network.
CONCLUSIONS: Current state-of-the-art artificial neural networks for general image analysis are able to detect cancer in mammographies with similar accuracy to radiologists, even in a screening-like cohort with low breast cancer prevalence.
引用
- Becker AS, Marcon M, Ghafoor S, et al. Deep Learning in Mammography: Diagnostic Accuracy of a Multipurpose Image Analysis Software in the Detection of Breast Cancer. Invest Radiol. 2017. PMID: 28212138. doi:10.1097/RLI.0000000000000358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。